webinar register page

Webinar banner
The Future of Science Beyond the Pandemic
In partnership with the British High Commission in Ottawa, CIFAR President & CEO Dr. Alan Bernstein and Sir Mark Walport, former Chief Executive of UK Research and Innovation, will discuss the impacts of the COVID-19 pandemic on the future of science with Rebecca Finlay, CIFAR Vice-President, Engagement & Public Policy. They will compare the social and public health approaches to disease prevention in Canada and the UK, and ask whether the pandemic will fundamentally alter how science is conducted.

Oct 26, 2020 11:00 AM in Eastern Time (US and Canada)

* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register

Speakers

Sir Mark Walport
Mark Walport retired as Chief Executive of UK Research and Innovation in 2020. Sir Mark took up the role in April 2017 and led the creation and implementation of the organisation for its first three years. He has held several distinguished senior positions of influence in research in the United Kingdom. During Mark’s tenure as Director of the Wellcome Trust, he oversaw the launch of the popular public Wellcome Collection. From 2013 to 2017 he was Chief Scientific Advisor to the UK Government and Permanent Secretary and Head of the Government Office for Science.
Dr. Alan Bernstein
Dr. Alan Bernstein is President & CEO of CIFAR, and is responsible for developing and leading the institute’s overall strategic direction. He served previously as executive director of the Global HIV Vaccine Enterprise in New York, an international alliance of funders charged with accelerating the search for an HIV vaccine. From 2000 to 2007, Alan served as the inaugural president of the Canadian Institutes of Health Research (CIHR), Canada’s federal agency for the support of health research. In that capacity, he led the transformation of health research in Canada. He is currently a member of Canada's Vaccine Task Force, which is advising the Government of Canada on COVID-19 vaccine candidates.
Rebecca Finlay
Rebecca Finlay is Vice-President, Engagement & Public Policy at CIFAR. She founded CIFAR’s global knowledge mobilization practice in 2014, bringing together experts in industry, civil society, healthcare and government to accelerate the societal impact of CIFAR’s research programs. In 2017, she was responsible for the launch of CIFAR’s AI & Society program to support international working groups and thought leadership on the questions AI poses for all aspects of policy and society. She leads CIFAR’s partnerships with governments and public sector organizations in Canada and worldwide. In 2019, she was honoured as a Fellow of the American Association for the Advancement of Science (AAAS).